Tudóstér: Fadel Lina publikációi

Kolostyák, Z., Bojcsuk, D., Baksa, V., Máthéné Szigeti, Z., Bene, K., Czimmerer, Z., Botó, P., Fadel, L., Póliska, S., Halász, L., Tzerpos, P., Berger, W., Villabona-Rueda, A., Varga, Z., Kovács, T., Patsalos, A., Pap, A., Vámosi, G., Bai, P., Dezső, B., Spite, M., D'Alessio,, F., Szatmári, I., Nagy, L.: EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages.
JCI Insight 9 (17), 1-21, 2024.

Rehó, B., Fadel, L., Brázda, P., Benziane, A., Hegedűs, É., Sen, P., Gadella, T., Tóth, K., Nagy, L., Vámosi, G.: Agonist-controlled competition of RAR and VDR nuclear receptors for heterodimerization with RXR is manifested in their DNA-binding.
J. Biol. Chem. 299 (2), 1-16, 2023.

Bosire, R., Fadel, L., Mocsár, G., Nánási, P., Sen, P., Sharma, A., Naseem, M., Kovács, A., Kugel, J., Kroemer, G., Vámosi, G., Szabó, G.: Doxorubicin impacts chromatin binding of HMGB1, Histone H1 and retinoic acid receptor.
Sci. Rep. 12 (1), 1-14, 2022.

Fadel, L., Rehó, B., Volkó, J., Bojcsuk, D., Kolostyák, Z., Nagy, G., Müller, G., Simándi, Z., Hegedűs, É., Szabó, G., Tóth, K., Nagy, L., Vámosi, G.: Agonist binding directs dynamic competition among nuclear receptors for heterodimerization with retinoid X receptor.
J. Biol. Chem. 295 (29), 10045-10061, 2020.

Rehó, B., Lau, L., Mocsár, G., Müller, G., Fadel, L., Brázda, P., Nagy, L., Tóth, K., Vámosi, G.: Simultaneous Mapping of Molecular Proximity and Comobility Reveals Agonist-Enhanced Dimerization and DNA Binding of Nuclear Receptors.
Anal. Chem. 92 (2), 2207-2215, 2020.